is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
CPhI South East Asia is the leading trading and conference platform for the ASEAN region. The event brings together 7,200+ domestic, regional and international pharma experts to do business, learn and share ideas that will shape the future of the ASEAN pharmaceutical and healthcare industry.
We divide our event into product-specific zones so you can make sure you're in the same area as the purchasers looking for your products:
CPhI: APIs, excipients, intermediates and more
P-MEC: machinery, technology and equipment
ICSE: contract manufacturing and services
InnoPack: packaging and drug delivery systems
LABworld: laboratory, analytical and biotech equipment
FDF: finished dosage formulations
CPhI SEA attracted many visitors, the first day was so busy that we didn’t even have a minute for a break: visitors were almost queuing at our stand to discuss business opportunities with us. Our mission on the show was to find partners and distributors in South East Asia and today I can say that it was accomplished. We gathered more than 100 contacts to work with. Having seen the result, we’ve made a decision to participate in CPhI SEA again next year.
CPhI 365 Digital Solutions offer you an effective way to promote your company to a global audience, generate quality leads, and position yourself as a thought leader within the pharmaceutical industry. Take advantage of our global network of 250,000+ Pharma professionals, extensive reach and market expertise to achieve your business objectives from the comfort of your home office.
DO NOT UNDER ANY CIRCUMSTANCES SIGN ANY FORMS FROM:
These companies target exhibitors through legitimate exhibition guides. These publications have no connection with us or any of our events. We strongly advise our exhibitors, and the entire exhibition community, to be most vigilant against this and similar organisations.